Equity Analysis

Quarterly Results

    Aurobindo Pharma Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
    BSE Code
    ISIN Demat
    Book Value()
    524804
    INE406A01037
    335.4746309
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    AUROPHARMA
    33.48
    69278.45
    EPS(TTM)
    Face Value()
    Div & Yield %:
    35.31
    1
    0.38
     
Quarters
(RupeeIcon Cr)
ParticularsSep 2024Jun 2024Mar 2024
Gross Sales2757.882425.222866.40
Other Operating Income66.7134.8727.63
Other Income 122.6665.32122.97
Total Income2947.252525.413017.00
Total Expenditure 2103.711961.162119.24
PBIDT843.54564.25897.76
Interest 51.6351.1353.07
PBDT791.91513.12844.69
Depreciation68.1666.8864.81
Tax188.43119.66207.66
Fringe Benefit Tax0.000.000.00
Deferred Tax-2.21-2.46-6.45
Reported Profit After Tax537.53329.04578.67
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item537.53329.04578.67
EPS (Unit Curr.)9.215.629.88
EPS (Adj) (Unit Curr.)9.215.629.88
Calculated EPS (Unit Curr.)9.255.629.88
Calculated EPS (Adj) (Unit Curr.)9.255.629.88
Calculated EPS (Ann.) (Unit Curr.)37.0222.4639.51
Calculated EPS (Adj) (Ann.) (Unit Curr.)37.0222.4639.51
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity58.0858.5958.59
Reserve & Surplus19598.160.000.00
Face Value1.001.001.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)30.5923.2731.32
PBDTM(%)28.7121.1629.47
PATM(%)19.4913.5720.19
Dividend Per Share(Rs)0.000.000.00
Diluted EPS9.215.629.88